Current treatment of asthma - focus on leukotrienes

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.5, 2000-07, pp. : 1021-1040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukotrienes as Mediators of Asthma

By Nicosia S. Capra V. Rovati G.E.

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 1, 2001-01 ,pp. : 3-19

Academic Press

Access to resources Recommend Favorite

Leukotrienes, Antileukotrienes and Asthma

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 647-656

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Leukotrienes for the Treatment of COPD?

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 4, 2009-09 ,pp. : 297-306

Bentham Science Publishers

Access to resources Recommend Favorite

Role of interactions in pharmacogenetic studies: leukotrienes in asthma

By Via Marc Tcheurekdjian Haig González Burchard Esteban

Pharmacogenomics, Vol. 14, Iss. 8, 2013-06 ,pp. : 923-929

Future Medicine

Access to resources Recommend Favorite

Role of Leukotrienes and Leukotriene Receptor Antagonists in Asthma

By Jones T.R. Rodger I.W.

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 107-110

Academic Press

Access to resources Recommend Favorite